المؤلفون: University of Washington, Seattle Cancer Care Alliance Proton Therapy Center, Seattle, WA ( host institution ), Tseng, Y.D. ( author ), Hoppe, B.S. ( UF author ), Miller, D. ( author ), Maity, A. ( author ), Nanda, R.H. ( UF author ), Mendenhall, N.P. ( UF author ), Flampouri, S. ( UF author ), Mohindra, P. ( author ), Hartsell, W.F. ( author ), Vargas, C.E. ( author ), Plastaras, J.P. ( author )

وصف الملف: Pages S62-S63

Relation: International Journal of Radiation Oncology*Biology*Physics; S0360301617312051; http://ufdc.ufl.edu/LS00592822/00001

الاتاحة: https://doi.org/10.1016/j.ijrobp.2017.06.155
http://ufdc.ufl.edu/LS00592822/00001

المؤلفون: Department of Radiation Oncology, University of Washington, Seattle Cancer Care Alliance Proton Therapy Center, Seattle, Washington ( host institution ), Tseng, Yolanda D. ( author ), Cutter, David J. ( author ), Plastaras, John P. ( author ), Parikh, Rahul R. ( author ), Cahlon, Oren ( author ), Chuong, Michael D. ( author ), Dedeckova, Katerina ( author ), Khan, Mohammad K. ( author ), Lin, Shinn-Yn ( author ), McGee, Lisa A. ( author ), Shen, Eric Yi-Liang ( author ), Terezakis, Stephanie A. ( author ), Badiyan, Shahed N. ( author ), Kirova, Youlia M. ( author ), Hoppe, Richard T. ( author ), Mendenhall, Nancy P. ( UF author ), Pankuch, Mark ( author ), Flampouri, Stella ( UF author ), Ricardi, Umberto ( author ), Hoppe, Bradford S. ( UF author )

وصف الملف: Pages 825-842

Relation: International Journal of Radiation Oncology*Biology*Physics; S036030161730901X; http://ufdc.ufl.edu/LS00592810/00001

الاتاحة: https://doi.org/10.1016/j.ijrobp.2017.05.004
http://ufdc.ufl.edu/LS00592810/00001

المؤلفون: Symonds, Lynn, Linden, Hannah, Gadi, Vijayakrishna, Korde, Larissa, Rodler, Eve, Gralow, Julie, Redman, Mary, Baker, Kelsey, Wu, Quan Vicky, Jenkins, Isaac, Kurland, Brenda, Garrison, Mitchell, Smith, Julie, Anderson, Jeanne, Van Haelst, Carol, Seattle Cancer Care Alliance Network Investigators, Specht, Jennifer

المصدر: Clinical Breast Cancer; Apr2019, Vol. 19 Issue 2, pe283-e296, 14p

المؤلفون: Ley, Timothy, Miller, Christopher, Ding, Li, Raphael, Benjamin J., Mungall, Andrew J., Robertson, A. Gordon, Hoadley, Katherine, Triche, Timothy J., Laird, Peter W., Baty, Jack D., Fulton, Lucinda L., Fulton, Robert, Heath, Sharon E., Kalicki Veizer, Joelle, Kandoth, Cyriac, Klco, Jeffery M., Koboldt, Daniel C., Kanchi, Krishna Latha, Shashikant Kulkarni, M. S. , P.h. D., F. A. C. M. G., Tamara L. Lamprecht, B. S., Washington University, S.t. Louis, David E. Larson, P.h. D., Ling Lin, M. S., Charles Lu, Michael D. McLellan, Joshua F. McMichael, the Genome Institute at Washington University, Jacqueline Payton, M. D. , P.h. D., Heather Schmidt, David H. Spencer, Michael H. Tomasson, M. D., Siteman Cancer Center, S.t. Louis, John W. Wallis, Lukas D. Wartman, Mark A. Watson, John Welch, Michael C. Wendl, Adrian Ally, B. S.c., Miruna Balasundaram, B. A. S.c., Inanc Birol, Yaron Butterfield, Readman Chiu, M. S.c., Andy Chu, Eric Chuah, Hye Jung Chun, Richard Corbett, Noreen Dhalla, Ranabir Guin, An He, Carrie Hirst, Martin Hirst, Robert A. Holt, Steven Jones, Aly Karsan, Darlene Lee, Haiyan I. Li, Marco A. Marra, Michael Mayo, Richard A. Moore, Karen Mungall, Jeremy Parker, Erin Pleasance, Patrick Plettner, Jacquie Schein, Dominik Stoll, Lucas Swanson, Angela Tam, Nina Thiessen, Richard Varhol, Natasja Wye, Yongjun Zhao, M. S.c. , D. V. M., British Columbia Cancer Agency's Genome Sciences Centre, Vancouver, Canada, Stacey Gabriel, Gad Getz, Carrie Sougnez, Lihua Zou, Broad Institute of Harvard, Massachusetts Institute of Technology, Cambridge, MA, Mark D. M. Leiserson, B. A., Hsin Ta Wu, Brown University, Center for Computational Molecular Biology, Providence, RI, Frederick Applebaum, Fred Hutchinson Cancer Research Center, Division of Medical Oncology, Seattle Cancer Care Alliance, Seattle, Stephen B. Baylin, Johns Hopkins University, Baltimore, Rehan Akbani, Bradley M. Broom, Ken Chen, Thomas C. Motter, B. A., Khanh Nguyen, John N. Weinstein, Nianziang Zhang, University of Texas M. D. Anderson Cancer Center, Houston, Martin L. Ferguson, MLF Consulting, Biotechnology Consultant, Boston, Christopher Adams, Aaron Black, Jay Bowen, Julie Gastier Foster, Thomas Grossman, Tara Lichtenberg, Lisa Wise, the Research Institute at Nationwide Children's Hospital, Columbus, OH, Tanja Davidsen, John A. Demchok, Kenna R. Mills Shaw, Margi Sheth, National Cancer Institute, Bethesda, MD, Heidi J. Sofia, P.h. D. , M. P. H., National Human Genome Research Institute, Liming Yang, James R. Downing, S.t. Jude Children's Research Hospital, Memphis, Greg Eley, Sciementis LLC, Statham, GA, Shelley Alonso, Brenda Ayala, Julien Baboud, Mark Backus, Sean P. Barletta, Dominique L. Berton, M. S. C. S., Anna L. Chu, Stanley Girshik, Mark A. Jensen, Ari Kahn, Prachi Kothiyal, Matthew C. Nicholls, Todd D. Pihl, David A. Pot, Rohini Raman, B. E., Rashmi N. Sanbhadti, Eric E. Snyder, Deepak Srinivasan, Jessica Walton, Yunhu Wan, Zhining Wang, SRA International, Fairfax, VA, Jean Pierre J. Issa, Temple University, Philadelphia, Michelle Le Beau, University of Chicago, Chicago, Martin Carroll, University of Pennsylvania, Hagop Kantarjian, M. D., Steven Kornblau, Moiz S. Bootwalla, B. S.c. , M. S., Phillip H. Lai, Hui Shen, David J. Van Den Berg, Daniel J. Weisenberger, University of Southern California, Epigenome Center, Los Angeles, Daniel C. Link, M. D., Matthew J. Walter, Bradley A. Ozenberger, Elaine R. Mardis, Peter Westervelt, Timothy A. Graubert, John F. DiPersio, Richard K. Wilson, VANDIN, FABIO

المساهمون: Ley, Timothy, Miller, Christopher, Ding, Li, Raphael, Benjamin J., Mungall, Andrew J., Robertson, A. Gordon, Hoadley, Katherine, Triche, Timothy J., Laird, Peter W., Baty, Jack D., Fulton, Lucinda L., Fulton, Robert, Heath, Sharon E., Kalicki Veizer, Joelle, Kandoth, Cyriac, Klco, Jeffery M., Koboldt, Daniel C., Kanchi, Krishna Latha, Shashikant, Kulkarni, M. S., P. h. D., F. A. C. M., G., Tamara L., Lamprecht, B., S., Washington, University, Louis, S. t., David E., Larson, P. h., D., Ling, Lin, M., S., Charles, Lu, Michael D., Mclellan, Joshua F., Mcmichael, the Genome Institute at Washington, University, Jacqueline, Payton, M. D., P. h. D., Heather, Schmidt, David H., Spencer, Michael H., Tomasson, M., D., Siteman Cancer Center, S. t. Loui, John W., Walli, Lukas D., Wartman, Mark A., Watson, John, Welch, Michael C., Wendl, Adrian, Ally, B. S., C., Miruna, Balasundaram, B. A. S., C., Inanc, Birol, Yaron, Butterfield, Readman, Chiu, M. S., C., Andy, Chu, Eric, Chuah, Hye Jung, Chun, Richard, Corbett, Noreen, Dhalla, Ranabir, Guin, An, He, Carrie, Hirst, Martin, Hirst, Robert A., Holt, Steven, Jone

مصطلحات موضوعية: Adult, CpG Island, DNA Methylation, Epigenomic, Female, Gene Expression, Gene Fusion, Genome, Human, Leukemia, Myeloid, Acute, Male, MicroRNA, Middle Aged, Sequence Analysis, DNA, Mutation

Relation: info:eu-repo/semantics/altIdentifier/pmid/23634996; info:eu-repo/semantics/altIdentifier/wos/WOS:000319574200004; volume:368; issue:22; firstpage:2059-74; lastpage:2074; journal:NEW ENGLAND JOURNAL OF MEDICINE; http://hdl.handle.net/11577/3194446; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84878372012

الاتاحة: http://hdl.handle.net/11577/3194446
https://doi.org/10.1056/NEJMoa1301689

المؤلفون: Bhatia, Vipul, Kamat, Nikhil V., Pariva, Tiffany E., Wu, Li-Ting, Tsao, Annabelle, Sasaki, Koichi, Sun, Huiyun, Javier, Gerardo, Nutt, Sam, Coleman, Ilsa, Hitchcock, Lauren, Zhang, Ailin, Rudoy, Dmytro, Gulati, Roman, Patel, Radhika A., Roudier, Martine P., True, Lawrence D., Srivastava, Shivani, Morrissey, Colm M., Haffner, Michael C., Nelson, Peter S., Priceman, Saul J., Ishihara, Jun, Lee, John K.

المساهمون: U.S. Department of Defense, Prostate Cancer Foundation, Seattle Cancer Care Alliance/Swim Across America Award, Fred Hutch/University of Washington Consortium Safeway Pilot Award, Japan Society for the Promotion of Science London, U.S. Department of Health & Human Services | NIH | National Cancer Institute, Instute for Prostate Cancer Research, Doris Duke Charitable Foundation

المصدر: Nature Communications ; volume 14, issue 1 ; ISSN 2041-1723

الاتاحة: http://dx.doi.org/10.1038/s41467-023-37874-2
https://www.nature.com/articles/s41467-023-37874-2.pdf
https://www.nature.com/articles/s41467-023-37874-2

المؤلفون: Grivas, P., Loriot, Y., Morales Barrera, Rafael, Teo, M. Y., Zakharia, Y., Feyerabend, S.

المساهمون: Institut Català de la Salut, Grivas P Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA 98109, USA. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. Seattle Cancer Care Alliance, Seattle, WA 98109, USA. Loriot Y Department of Medicine, Gustave Roussy Cancer Campus, INSERM U981, Université Paris-Saclay, 94800 Villejuif, France. Morales-Barrera R Vall d’Hebron Hospital Universitari, Barcelona, Spain. Teo MY Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Zakharia Y Division of Hematology, Oncology, and Blood and Marrow Transplant, University of Iowa and Holden Comprehensive Cancer Center, Iowa City, IA 52242, USA. Feyerabend S Studienpraxis Urologie, 72622 Nürtingen, Germany, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Bufeta - Càncer - Tractament, Inhibidors enzimàtics - Ús terapèutic - Eficàcia, DISEASES::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Urologic Neoplasms::Urinary Bladder Neoplasms, Other subheadings::Other subheadings::Other subheadings::/drug therapy, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Poly(ADP-ribose) Polymerase Inhibitors, Other subheadings::Other subheadings::Other subheadings::/administration & dosage, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias urológicas::neoplasias de la vejiga, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::mecanismos moleculares de acción farmacológica::inhibidores enzimáticos::inhibidores de poli(ADP-ribosa) polimerasas, Otros calificadores::Otros calificadores::Otros calificadores::/administración & dosificación

وصف الملف: application/pdf

Relation: BMC Cancer;21; https://doi.org/10.1186/s12885-021-08085-z; Grivas P, Loriot Y, Morales-Barrera R, Teo MY, Zakharia Y, Feyerabend S, et al. Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS). BMC Cancer. 2021 May 24;21:593.; https://hdl.handle.net/11351/7057; 000657731100001

الاتاحة: https://hdl.handle.net/11351/7057
https://doi.org/10.1186/s12885-021-08085-z

المؤلفون: Borghaei, Hossein, Gettinger, Scott, Vokes, Everett, Chow, Laura, Burgio, Marco Angelo, de Castro Carpeno, Javier, Felip Font, Enriqueta

المساهمون: Institut Català de la Salut, Borghaei H Fox Chase Cancer Center, Philadelphia, PA. Gettinger S Yale Comprehensive Cancer Center, New Haven, CT. Vokes EE Univeristy of Chicago Medicine and Biologic Sciences Division, Chicago, IL. Chow LQM University of Washington, Seattle Cancer Care Alliance, Seattle, WA. Burgio MA Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. de Castro Carpeno J Hospital De Madrid, Norte Sanchinarro, Madrid, Spain. Felip E Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Avaluació de resultats (Assistència sanitària), Pulmons - Càncer - Tractament, Immunoteràpia, DISEASES::Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung, Other subheadings::Other subheadings::Other subheadings::/drug therapy, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias torácicas::neoplasias del tracto respiratorio::neoplasias pulmonares::neoplasias de los bronquios::carcinoma broncogénico::carcinoma de pulmón de células no pequeñas, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::inmunomodulación::inmunoterapia, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento

وصف الملف: application/pdf

Relation: Journal of Clinical Oncology;39(7); https://doi.org/10.1200/JCO.20.01605; Borghaei H, Gettinger S, Vokes EE, Chow LQM, Burgio MA, de Castro Carpeno J, et al. Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer. J Clin Oncol. 2021 Mar 1;39(7):723–33.; https://hdl.handle.net/11351/7634; 000635371200005

الاتاحة: https://hdl.handle.net/11351/7634
https://doi.org/10.1200/JCO.20.01605

المؤلفون: Schmid, Sabine, Omlin, Aurelius, Higano, Celestia, Sweeney, Christopher, Martinez Chanza, Nieves, Mehra, Niven, Morales Barrera, Rafael

المساهمون: Institut Català de la Salut, Schmid S Department of Medical Oncology and Haematology, Cantonal Hospital of St Gallen, St Gallen, Switzerland. Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. Omlin A Department of Medical Oncology and Haematology, Cantonal Hospital of St Gallen, St Gallen, Switzerland. Higano C Seattle Cancer Care Alliance, University of Washington, Seattle. Sweeney C, Martinez Chanza N Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts. Mehra N Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. Morales-Barrera R Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Pròstata - Càncer - Quimioteràpia, ADN - Reparació, DISEASES::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Male::Prostatic Neoplasms, Other subheadings::Other subheadings::Other subheadings::/drug therapy, DISEASES::Nutritional and Metabolic Diseases::Metabolic Diseases::DNA Repair-Deficiency Disorders, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales masculinos::neoplasias de la próstata, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, ENFERMEDADES::enfermedades nutricionales y metabólicas::enfermedades metabólicas::trastornos por deficiencias en la reparación del ADN

وصف الملف: application/pdf

Relation: Jama Network Open;3(10); https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2772301; Schmid S, Omlin A, Higano C, Sweeney C, Martinez Chanza N, Mehra N, et al. Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations. JAMA Netw Open. 2020 Oct 28;3(10):e2021692.; https://hdl.handle.net/11351/6340; 000588112500001

الاتاحة: https://hdl.handle.net/11351/6340
https://doi.org/10.1001/jamanetworkopen.2020.21692

المؤلفون: Shands, Mary Ellen, Lewis, Frances Marcus

المساهمون: Safeway Foundation, Thoracic, Head and Neck Oncology Research Program of the Seattle Cancer Care Alliance

المصدر: American Journal of Hospice and Palliative Medicine® ; volume 38, issue 8, page 920-926 ; ISSN 1049-9091 1938-2715

الاتاحة: https://doi.org/10.1177/1049909120969120
https://journals.sagepub.com/doi/pdf/10.1177/1049909120969120
https://journals.sagepub.com/doi/full-xml/10.1177/1049909120969120

المؤلفون: Sosa-Moreno, Andrea, Narita, Masahiro, Spitters, Christopher, Swetky, Michelle, Podczervinski, Sara, Lind, Margaret L, Holmberg, Leona, Liu, Catherine, Edelstein, Raleigh, Pergam, Steven A

المساهمون: National Cancer Institute, Seattle Cancer Care Alliance Summer Infection Prevention Intern Support

المصدر: Open Forum Infectious Diseases ; volume 7, issue 7 ; ISSN 2328-8957

مصطلحات موضوعية: Infectious Diseases, Oncology

الاتاحة: http://dx.doi.org/10.1093/ofid/ofaa224
http://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofaa224/33376559/ofaa224.pdf
http://academic.oup.com/ofid/article-pdf/7/7/ofaa224/33479952/ofaa224.pdf

المساهمون: McClure, R [Seattle Cancer Care Alliance, Seattle, WA (United States)]

المصدر: Medical Physics; 43; 6; Other Information: (c) 2016 American Association of Physicists in Medicine; Country of input: International Atomic Energy Agency (IAEA)

وصف الملف: Medium: X; Size: vpage(s)

URL الوصول: http://www.osti.gov/scitech/biblio/22649351

المساهمون: Richardson, H [Seattle Cancer Care Alliance, Seattle, WA (United States)]

المصدر: Medical Physics; 43; 6; Other Information: (c) 2016 American Association of Physicists in Medicine; Country of input: International Atomic Energy Agency (IAEA)

وصف الملف: Medium: X; Size: vpage(s)

URL الوصول: http://www.osti.gov/scitech/biblio/22649088

المساهمون: Holloway, K [Seattle Cancer Care Alliance, Seattle, WA (United States)]

المصدر: Medical Physics; 41; 6; Other Information: (c) 2014 American Association of Physicists in Medicine; Country of input: International Atomic Energy Agency (IAEA)

وصف الملف: Medium: X; Size: page(s) 162

URL الوصول: http://www.osti.gov/scitech/biblio/22325204

المؤلفون: Maarten Albersen, Piet Ost, Giacomo Novara, James W.F. Catto, Todd M. Morgan, Sarah P. Psutka, Elizabeth R. Plimack, Jean-Nicolas Cornu

المساهمون: Department of Urology, University of Washington, Seattle Cancer Care Alliance, Seattle, WA, USA, Editorial Board, European Urology, Elsevier and European Association of Urology, Arnhem, The Netherlands, Department of Urology, University of Michigan, Ann Arbor, MI, USA, Editorial Board, European Urology, Elsevier and European Association of Urology, Department of Urology, Katholieke Univeriteit Leuven, Nutrition, inflammation et dysfonctionnement de l'axe intestin-cerveau (ADEN), Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institute for Research and Innovation in Biomedicine (IRIB), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), UNIROUEN - UFR Santé (UNIROUEN UFR Santé), Normandie Université (NU)-Normandie Université (NU), Service d'urologie [Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU), Department of Surgery, Oncology, and Gastroenterology, Urology Clinic, University of Padua, Division of Genitourinary Medical Oncology, Fox Chase Cancer Center, Department of Radiation Oncology, Iridium Network, GZA Ziekenhuizen, Department of Human Structure and Repair, Ghent University, Department of Oncology and Metabolism, University of Sheffield, Editor in Chief, European Urology, Elsevier and European Association of Urology

المصدر: European Urology
European Urology, Elsevier, 2021, 80 (4), pp.450-453. ⟨10.1016/j.eururo.2021.07.002⟩

مصطلحات موضوعية: Economic growth, Gender equity, Cognitive diversity, business.industry, Urology, media_common.quotation_subject, 030232 urology & nephrology, Equity (finance), 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, [SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO], Medicine, business, ComputingMilieux_MISCELLANEOUS, Diversity (politics), media_common

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04e6354ab30c185c321159c325945065
https://hal-normandie-univ.archives-ouvertes.fr/hal-03520843

المؤلفون: Markus Wohlleber, Hossein Borghaei, Scott N. Gettinger, Everett E. Vokes, Wilfried Enst Erich Eberhardt, David M. Waterhouse, Enriqueta Felip, Charles Butts, Marco Angelo Burgio, Laura Q.M. Chow, David R. Spigel, Osvaldo Arén Frontera, Miriam Alonso Garcia, Joanna Wojcik-Tomaszewska, Manuel Domine, Scott J. Antonia, Fabrice Barlesi, Rita Chiari, Adam Pluzanski, S. Marimuthu, Grzegorz Czyzewicz, Ang Li, Lucio Crinò, David E. Gerber, Julie R. Brahmer, Neal Ready, Oscar Arrieta, Marina Chiara Garassino, Bruno Coudert, Javier de Castro Carpeño

المساهمون: Institut Català de la Salut, [Borghaei H] Fox Chase Cancer Center, Philadelphia, PA. [Gettinger S] Yale Comprehensive Cancer Center, New Haven, CT. [Vokes EE] Univeristy of Chicago Medicine and Biologic Sciences Division, Chicago, IL. [Chow LQM] University of Washington, Seattle Cancer Care Alliance, Seattle, WA. [Burgio MA] Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. [de Castro Carpeno J] Hospital De Madrid, Norte Sanchinarro, Madrid, Spain. [Felip E] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia
J Clin Oncol

مصطلحات موضوعية: Oncology, Male, Cancer Research, Phase iii trials, Lung Neoplasms, Time Factors, Checkmate, Medizin, Immunoteràpia, Docetaxel, Other subheadings::Other subheadings::/drug therapy [Other subheadings], 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, 030212 general & internal medicine, Immune Checkpoint Inhibitors, Randomized Controlled Trials as Topic, Aged, 80 and over, terapéutica::terapia biológica::inmunomodulación::inmunoterapia [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Middle Aged, Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung [DISEASES], Progression-Free Survival, Tubulin Modulators, Nivolumab, 030220 oncology & carcinogenesis, Disease Progression, Female, Non small cell, Immunotherapy, medicine.drug, Adult, medicine.medical_specialty, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], 03 medical and health sciences, Young Adult, Internal medicine, medicine, Humans, Lung cancer, Aged, Errata, business.industry, Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], diagnóstico::pronóstico::resultado del tratamiento [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], neoplasias::neoplasias por localización::neoplasias torácicas::neoplasias del tracto respiratorio::neoplasias pulmonares::neoplasias de los bronquios::carcinoma broncogénico::carcinoma de pulmón de células no pequeñas [ENFERMEDADES], medicine.disease, Diagnosis::Prognosis::Treatment Outcome [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Clinical Trials, Phase III as Topic, Avaluació de resultats (Assistència sanitària), Previously treated, business, Pulmons - Càncer - Tractament

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d89b8198e8ce6230aa2c1dd4a7f7a11b
https://hdl.handle.net/11351/7634

المؤلفون: Smith, Stephen D., Reddy, Prathima, Sokolova, Alexandra, Chow, Victor A., Lynch, Ryan C., Shadman, Mazyar A., Till, Brian G., Shustov, Andrei R., Warren, Edus H., Ujjani, Chaitra S., Menon, Manoj P., Tseng, Yolanda D., Gopal, Ajay K.

المساهمون: STTR, Seattle Cancer Care Alliance, Frank and Betty Vandermeer

المصدر: American Journal of Hematology ; volume 94, issue 4 ; ISSN 0361-8609 1096-8652

الاتاحة: http://dx.doi.org/10.1002/ajh.25411
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fajh.25411
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25411
https://onlinelibrary.wiley.com/doi/full-xml/10.1002/ajh.25411

المؤلفون: Olszanski, Anthony J., Smith, David C., Camacho, Luis H., Thompson, John, Ramalingam, Suresh S., Harvey, R. Donald, Campos, Luis, Ferry, David, Tang, Shande, Gao, Ling, Safran, Howard

المساهمون: University of Michigan, Ann Arbor, Michigan, USA, Eli Lilly and Company, Bridgewater, New Jersey, USA, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA, Center for Oncology and Blood Disorders, Houston, Texas, USA, Seattle Cancer Care Alliance, Seattle, Washington, USA, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA, Oncology Consultants, Houston, Texas, USA, Rhode Island Hospital, Providence, Rhode Island, USA

مصطلحات موضوعية: Hematology and Oncology, Health Sciences

وصف الملف: application/pdf

Relation: Olszanski, Anthony J.; Smith, David C.; Camacho, Luis H.; Thompson, John; Ramalingam, Suresh S.; Harvey, R. Donald; Campos, Luis; Ferry, David; Tang, Shande; Gao, Ling; Safran, Howard (2016). "Electrocardiographic Characterization of Ramucirumab on the Corrected QT Interval in a Phase II Study of Patients With Advanced Solid Tumors." The Oncologist 21(4): 402-403f.; http://hdl.handle.net/2027.42/139908; The Oncologist; EG Chiorean, HI Hurwitz, RB Cohen. Phase I study of every 2‐ or 3‐week dosing of ramucirumab, a human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor‐2 in patients with advanced solid tumors. Ann Oncol. 2015; 26: 1230 – 1237.; U.S. Department of Health and Human Services. Guidance for industry: E14: clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non‐antiarrhythmic drugs. Available at http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm073153.pdf. Accessed September 22, 2015; JL Spratlin, RB Cohen, M Eadens. Phase I pharmacologic and biologic study of ramucirumab (IMC‐1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor‐2. J Clin Oncol. 2010; 28: 780 – 787.; CL Bello, M Mulay, X Huang. Electrocardiographic characterization of the QTc interval in patients with advanced solid tumors: Pharmacokinetic‐pharmacodynamic evaluation of sunitinib. Clin Cancer Res. 2009; 15: 7045 – 7052.; Y Liu, Y Liu, ZW Fan. Meta‐analysis of the risks of hypertension and QTc prolongation in patients with advanced non‐small cell lung cancer who were receiving vandetanib. Eur J Clin Pharmacol. 2015; 71: 541 – 547.; J Tabernero, T Yoshino, AL Cohn. Ramucirumab versus placebo in combination with second‐line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first‐line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): A randomised, double‐blind, multicentre, phase 3 study [published correction appears in Lancet Oncol 2015;16:e262]. Lancet Oncol. 2015; 16: 499 – 508.; EB Garon, TE Ciuleanu, O Arrieta. Ramucirumab plus docetaxel versus placebo plus docetaxel for second‐line treatment of stage IV non‐small‐cell lung cancer after disease progression on platinum‐based therapy (REVEL): A multicentre, double‐blind, randomised phase 3 trial. Lancet. 2014; 384: 665 – 673.; H Wilke, K Muro, E Van Cutsem. Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro‐oesophageal junction adenocarcinoma (RAINBOW): A double‐blind, randomised phase 3 trial. Lancet Oncol. 2014; 15: 1224 – 1235.; U.S. Department of Health and Human Services. National Cancer Institute Common Terminology Criteria for Adverse Events version 4.0. Available at http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm#ctc_40. Accessed February 21, 2016; CS Fuchs, J Tomasek, CJ Yong. Ramucirumab monotherapy for previously treated advanced gastric or gastro‐oesophageal junction adenocarcinoma (REGARD): An international, randomised, multicentre, placebo‐controlled, phase 3 trial. Lancet. 2014; 383: 31 – 39.

الاتاحة: http://hdl.handle.net/2027.42/139908
https://doi.org/10.1634/theoncologist.2015-0467

المؤلفون: Cohen, Stacey A., Wu, Chen, Yu, Ming, Gourgioti, Georgia, Wirtz, Ralph, Raptou, Georgia, Gkakou, Chryssa, Kotoula, Vassiliki, Pentheroudakis, George, Papaxoinis, George, Karavasilis, Vasilios, Pectasides, Dimitrios, Kalogeras, Konstantine T., Fountzilas, George, Grady, William M.

المساهمون: Seattle Cancer Care Alliance Development, National Institutes of Health

المصدر: Clinical Colorectal Cancer ; volume 15, issue 2, page 164-169 ; ISSN 1533-0028

الاتاحة: http://dx.doi.org/10.1016/j.clcc.2015.10.005
https://api.elsevier.com/content/article/PII:S1533002815001449?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1533002815001449?httpAccept=text/plain

المؤلفون: Higano, Celestia S., Corman, John M., Smith, David C., Centeno, Arthur S., Steidle, Christopher P., Gittleman, Marc, Simons, Jonathan W., Sacks, Natalie, Aimi, Junko, Small, Eric J.

المساهمون: Departments of Internal Medicine and Urology, University of Michigan Medical Center, Ann Arbor, Michigan, Departments of Oncology and Urology, University of Washington, Seattle, Seattle, Washington, Fax: (650) 595-0180, Seattle Cancer Care Alliance, 825 Eastlake Ave. E, P.O. Box 19023, Seattle, WA 98109-1023, Floyd and Delores Jones Cancer Center, Virginia Mason Medical Center, Seattle, Washington, Urology San Antonio, San Antonio, Texas, Northeast Indiana Research, Fort Wayne, Indiana, South Florida Medical Research, Aventura, Florida, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, J.W. Simons is a coinventor of 2 issued US patents (US Pat. Nos. 7,226,606 and 7,217,421), has pending applications that are exclusively licensed to and co-owned by Cell Genesys, and has received honoraria from Cell Genesys for speaking engagements., Department of Clinical Research, Cell Genesys, Inc, South San Francisco, California, N. Sacks and J. Aimi are employees of Cell Genesys., Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California

مصطلحات موضوعية: Life and Medical Sciences, Cancer Research, Oncology and Pathology, Oncology and Hematology, Public Health, Health Sciences

وصف الملف: 193021 bytes; 3118 bytes; application/pdf; text/plain

Relation: Higano, Celestia S.; Corman, John M.; Smith, David C.; Centeno, Arthur S.; Steidle, Christopher P.; Gittleman, Marc; Simons, Jonathan W.; Sacks, Natalie; Aimi, Junko; Small, Eric J. (2008). "Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer All patients provided informed consent. ." Cancer 113(5): 975-984.; https://hdl.handle.net/2027.42/60980; http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18646045&dopt=citation; http://dx.doi.org/10.1002/cncr.23669; Cancer

الاتاحة: https://hdl.handle.net/2027.42/60980
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18646045&dopt=citation
https://doi.org/10.1002/cncr.23669

المؤلفون: Daniel Vargas Pivato de Almeida, Sabine Schmid, Hiroyoshi Suzuki, Celestia S. Higano, Rafael Morales-Barrera, Elisa Ledet, Kostas Karalis, Ursina Zürrer-Härdi, Aurelius Omlin, Andries M. Bergman, Aaron R. Hansen, Elena Castro, Dirk Klingbiel, Pernelle Lavaud, William Oh, Nieves Martinez Chanza, Steven Yip, Malou C.P. Kuppen, Tomasz M. Beer, Silke Gillessen, Himisha Beltran, Che-Kai Tsao, Fernando C. Maluf, Ugo De Giorgi, Christopher Sweeney, Carmel Pezaro, Oliver Sartor, Giuseppe Di Lorenzo, Vincenza Conteduca, Marcello Tucci, Niven Mehra, Andrea Zivi, Kim N. Chi, Mo Linh Le, Diletta Bianchini, Sämi Schär

المساهمون: Institut Català de la Salut, [Schmid S] Department of Medical Oncology and Haematology, Cantonal Hospital of St Gallen, St Gallen, Switzerland. Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. [Omlin A] Department of Medical Oncology and Haematology, Cantonal Hospital of St Gallen, St Gallen, Switzerland. [Higano C] Seattle Cancer Care Alliance, University of Washington, Seattle. [Sweeney C, Martinez Chanza N] Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts. [Mehra N] Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. [Morales-Barrera R] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, Health Technology Assessment (HTA)

المصدر: Università degli studi di Foggia-IRIS
JAMA Network Open
Scientia
JAMA network open, 3(10). American Medical Association
JAMA Network Open, 3
JAMA Network Open, 3, 10

مصطلحات موضوعية: Pròstata - Càncer - Quimioteràpia, Oncology, ADN - Reparació, medicine.medical_specialty, Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Male::Prostatic Neoplasms [DISEASES], Combination therapy, Population, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Other subheadings::Other subheadings::/drug therapy [Other subheadings], Prostate cancer, SDG 3 - Good Health and Well-being, Nutritional and Metabolic Diseases::Metabolic Diseases::DNA Repair-Deficiency Disorders [DISEASES], Internal medicine, Medicine, education, Original Investigation, education.field_of_study, business.industry, Research, enfermedades nutricionales y metabólicas::enfermedades metabólicas::trastornos por deficiencias en la reparación del ADN [ENFERMEDADES], Retrospective cohort study, General Medicine, Evaluable Disease, medicine.disease, neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales masculinos::neoplasias de la próstata [ENFERMEDADES], Online Only, Prostate-specific antigen, Docetaxel, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], Cohort, business, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba024468bfdef5a4e348b95e58194637
https://fair.unifg.it/handle/11369/407886